The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
Authors
Keywords
-
Journal
NATURE GENETICS
Volume 45, Issue 5, Pages 522-525
Publisher
Springer Nature
Online
2013-03-18
DOI
10.1038/ng.2583
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Subset-Based Approach Improves Power and Interpretation for the Combined Analysis of Genetic Association Studies of Heterogeneous Traits
- (2012) Samsiddhi Bhattacharjee et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index
- (2012) J. Slotta-Huspenina et al. HAEMATOLOGICA
- Patterns of Cis Regulatory Variation in Diverse Human Populations
- (2012) Barbara E. Stranger et al. PLoS Genetics
- Mechanisms that Promote and Suppress Chromosomal Translocations in Lymphocytes
- (2011) Monica Gostissa et al. Annual Review of Immunology
- Pathogenesis of Myeloma
- (2011) Kenneth C. Anderson et al. Annual Review of Pathology-Mechanisms of Disease
- A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
- (2011) Siwanon Jirawatnotai et al. NATURE
- Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
- (2011) Peter Broderick et al. NATURE GENETICS
- The prognostic significance of cytogenetics and molecular profiling in multiple myeloma
- (2011) Jeffrey R. Sawyer Cancer Genetics
- The Architecture of Gene Regulatory Variation across Multiple Human Tissues: The MuTHER Study
- (2011) Alexandra C. Nica et al. PLoS Genetics
- Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
- (2010) P. Perez-Galan et al. BLOOD
- Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma
- (2010) Pia Fernberg et al. CANCER CAUSES & CONTROL
- Alternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response
- (2010) Z. Li et al. CANCER RESEARCH
- Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation
- (2010) K. Neben et al. HAEMATOLOGICA
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- Cyclin K and cyclin D1b are oncogenic in myeloma cells
- (2010) Véronique Marsaud et al. Molecular Cancer
- Data quality control in genetic case-control association studies
- (2010) Carl A Anderson et al. Nature Protocols
- Common Regulatory Variation Impacts Gene Expression in a Cell Type-Dependent Manner
- (2009) A. S. Dimas et al. SCIENCE
- Cyclin D1 Pro241Pro (CCND1-G870A) Polymorphism Is Associated with Increased Cancer Risk in Human Populations: A Meta-Analysis
- (2008) N. Pabalan et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1Binding and Cell Migration
- (2008) Zhiping Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now